California Cancer Reporting System Standards, Volume III
CCR ID |
NAACCR ID |
E1173 |
2852 |
AJCC
The presence of metastatic brain disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites. Effective for cases diagnosed 2010+.
Tumors, Admissions
1
er1039 CS Mets at Dx-Brain (2010)
0, 1, 8, 9 |
Site specific |
Blank |
Year of Diagnosis is before 2010 or after 2015 |
See the most current version of the Collaborative Stage Data Collection System (http://cancerstaging.org) for rules and site-specific codes and coding structures.
Note: This includes only the brain, not spinal cord or other parts of the central nervous system.
See CS Version Derived.
See CS Mets at DX--Bone.
Yes
IF385 CS Items, Type Reporting Source-DCO
IF846 CS Mets at DX, Rectum Schema (CS)
IF848 CS Mets at DX, Colon Schema (CS)
IF852 CS Mets at DX--Brain, CS Mets at DX
IF878 CS Items - SEER Required - Non-SSF (CS)
IF1104 CS Mets at DX-BBLL, LymphomaOcularAdnexa
IF1105 CS Mets at DX-BBLL, MycosisFungoides
N/A
2010 |
New data item for 2010. CSv1 to CSv2 Conversion Specs documentation states to leave these blank (see https://cancerstaging.org/cstage/coding/Documents/csv1tocsv2conversionspecs.pdf).
Added IF #846, 848, 850, and 878. Updated the description section. |
05/2016 |
Per NAACCR v16, CS Mets at DX-Brain is no longer required for DX Year 2016 and forward. Updated description and codes to match NAACCR. Update logic revised to follow new year requirements. |